Lexeo Therapeutics price target raised to $23 from $21 at H.C. Wainwright
The Fly

Lexeo Therapeutics price target raised to $23 from $21 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Lexeo Therapeutics (LXEO) to $23 from $21 and keeps a Buy rating on the shares after alignment was reached the with FDA on a registrational path for LX2006.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App